Ebanga

Active Ingredient(s): Ansuvimab-zykl
FDA Approved: * December 21, 2020
Pharm Company: * RIDGEBACK BIOTHERAPEUTICS
Category: Antiviral

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.[1][2] The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.[1] Ansuvimab was approved for medical use in the United States in Decem... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.